BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2252558)

  • 21. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Randomized Clinical Trial on the Impact of Individually Targeted Computerized Cognitive Training on Quality of Life Indicators in Adults With HIV-Associated Neurocognitive Disorder in the Southeastern United States.
    Vance DE; Pope CN; Fazeli PL; Azuero A; Frank JS; Wadley VG; Raper JL; Byun JY; Ball KK
    J Assoc Nurses AIDS Care; 2022 May-Jun 01; 33(3):295-310. PubMed ID: 34864757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-associated neurocognitive disorders (HAND).
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
    Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychiatric morbidity in HIV patients.
    Khouzam HR; Donnelly NJ; Ibrahim NF
    Can J Psychiatry; 1998 Feb; 43(1):51-6. PubMed ID: 9494747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a profile of medically ill psychiatric patients.
    Walter-Ryan WG; Alarcon RD; Meadows DT; Westbrook R
    South Med J; 1987 Jul; 80(7):822-6. PubMed ID: 3603102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mental health aspects of HIV infection.
    Hunter J
    Can Fam Physician; 1993 Jun; 39():1415-8, 1421-4. PubMed ID: 8324410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
    Parry S; Zetler S; Kentridge A; Petrak J; Barber T
    AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage secretome from women with HIV-associated neurocognitive disorders.
    Colon K; Perez-Laspiur J; Quiles R; Rodriguez Y; Wojna V; Shaffer SA; Leszyk J; Skolasky RL; Melendez LM
    Proteomics Clin Appl; 2016 Feb; 10(2):136-43. PubMed ID: 26220577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders].
    Rothenhäusler HB
    Wien Med Wochenschr; 2006 Dec; 156(23-24):644-56. PubMed ID: 17211770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactions to a Probable Diagnosis of HIV-Associated Neurocognitive Disorder: A Content Analysis.
    Vance DE; Robinson J; Walker TJ; Tende F; Bradley B; Diehl D; McKie P; Fazeli PL
    J Assoc Nurses AIDS Care; 2020; 31(3):279-289. PubMed ID: 31436599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 infection and neurocognitive impairment in the current era.
    del Palacio M; Alvarez S; Muñoz-Fernández MÁ
    Rev Med Virol; 2012 Jan; 22(1):33-45. PubMed ID: 21990255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa.
    Joska JA; Westgarth-Taylor J; Myer L; Hoare J; Thomas KG; Combrinck M; Paul RH; Stein DJ; Flisher AJ
    AIDS Behav; 2011 Aug; 15(6):1197-203. PubMed ID: 20614176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.
    Valcour VG; Shikuma CM; Watters MR; Sacktor NC
    AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S79-86. PubMed ID: 15075502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropsychological changes in drug addicts infected with human immunodeficiency virus].
    Sopelana P; Débora M; López-Calvo S; García-Alvarez JC; Polo C
    Arch Neurobiol (Madr); 1992; 55(5):228-34. PubMed ID: 1482276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-related ocular microangiopathic syndrome and neuropsychological functioning.
    Perro C; Geier SA; Naber D; Klauss V; Kronawitter U; Bogner JR; Goebel ED
    AIDS; 1993 Apr; 7(4):595-6. PubMed ID: 8507426
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
    Vance DE; Brew BJ
    AIDS; 2021 Mar; 35(3):511-513. PubMed ID: 33507007
    [No Abstract]   [Full Text] [Related]  

  • 38. Health-Related Everyday Functioning in the Internet Age: HIV-Associated Neurocognitive Disorders Disrupt Online Pharmacy and Health Chart Navigation Skills.
    Woods SP; Iudicello JE; Morgan EE; Cameron MV; Doyle KL; Smith TV; Cushman C;
    Arch Clin Neuropsychol; 2016 Mar; 31(2):176-85. PubMed ID: 26743327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-related mental health nursing issues.
    Hall JM; Koehler SL; Lewis A
    Semin Oncol Nurs; 1989 Nov; 5(4):276-83. PubMed ID: 2682881
    [No Abstract]   [Full Text] [Related]  

  • 40. [HIV infection associated cognitive disorders].
    Manea M; Ruşanu V; Patrichi BE; Stoean R; Pădurariu A; Puiu GM
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):598-601. PubMed ID: 20201238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.